Government has taken various regulatory measures since 2019 to ensure the quality of medicinal products in country
The Government has taken various regulatory measures since 2019 to ensure the quality of medicines in the country. The key measures are as under: The Drugs Rules, 1945 were amended providing that every Active Pharmaceutical Ingredient (bulk drug) manufactured or imported in India shall bear Quick Response Code on its label. The stored data or […]
Transplantation of Human Organs & Tissues Act (THOTA), 1994 provides for regulation of removal, storage and transplantation of human organs & tissues for therapeutic purposes
The Transplantation of Human Organs & Tissues Act (THOTA), 1994 provides for regulation of removal, storage and transplantation of human organs & tissues for therapeutic purposes and for prevention of commercial dealings in human organs & tissues. The subject of artificial organs is not regulated under the aforesaid Act. As reported by Directorate General of […]
National Tuberculosis Control Programme
The Government has implemented the National TB Elimination Programme (NTEP) under the aegis of the National Health Mission (NHM). With the goal of achieving Sustainable Development Goals related to TB by 2025, five years ahead of the global targets, the programme has implemented a National Strategic Plan with the following objectives: - Early diagnosis of […]
Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus
Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status. The Elecsys HCV Duo immunoassay enables significantly earlier diagnosis of active HCV infection, making it possible to get patients appropriate care sooner to stop both the disease progression and […]
Virtual Press Conference on COVID-19 and other global health issues
About WHO The World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States, across six regions and from more than 150 offices, to promote health, keep the world safe and serve the vulnerable. Our goal for 2019-2023 is to ensure that a […]
National Health Authority commences the first Hackathon under the ‘ABDM Hackathon Series’ in Pune, Maharashtra
The National Health Authority (NHA) is organising its first hackathon under the Ayushman Bharat Digital Mission Hackathon Series from 14th to 17th July, 2022 at the Smart City Operations Centre, Pune, Maharashtra in hybrid format. The hackathon is being organized under the Ayushman Bharat Digital Mission (ABDM) in association with Pune Municipal Corporation (PMC) and […]
New two-year data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration
In the TENAYA and LUCERNE studies, more than 60% of Vabysmo patients could be treated every four months at two years. This represents an increase from 45% at year one Patients treated with Vabysmo received a median number of 10 injections over the two years versus 15 injections for those treated with aflibercept, potentially decreasing […]
Union Health Minister Dr Mansukh Mandaviya interacts with State Health Ministers; reviews status and progress under “HarGharDastak 2.0”
“COVID is not over yet. There are reports of rising cases of COVID in some states. It is important at this time to be alert and not forget COVID Appropriate behaviour (CAB) such as wearing masks and maintaining physical distance to prevent spread of the infection”. This was stressed by Union Minister for Health and […]
FDA grants Priority Review to Roche’s Lunsumio for people with relapsed or refractory follicular lymphoma
Lunsumio® (mosunetuzumab) could be the first CD20xCD3 T-cell engaging bispecific antibody approved by the FDA for the treatment of any type of non-Hodgkin lymphoma Application is based on results from the pivotal phase I/II study showing Lunsumio induced high and durable complete response rates in people with follicular lymphoma who received two or more prior […]
WHO advises against use of two drugs for non-severe covid-19
Current evidence does not justify using colchicine to treat non-severe illness, and fluvoxamine shouldn’t be used outside of clinical trials The antidepressant drug fluvoxamine and the gout drug colchicine are not recommended for patients with mild or moderate covid-19 because there is currently insufficient evidence that they improve important outcomes for patients, and both drugs […]
